SITC Cancer Immunotherapy CONNECT

 

Register Today for Pittsburgh & New Haven Advances in Cancer Immunotherapy™ Programs

Join SITC for Advances in Cancer Immunotherapy™ (ACI) programs Sept. 14 in Pittsburgh, PA and Sept. 16 in New Haven, CT. Learn clinical applications of immunotherapy for disease states with FDA-approved treatments and much more!

Register Today for an ACI

 

Join SITC at the 32nd Annual Meeting & Pre-Conference Programs

SITC 2017 is the premier destination for scientific exchange, education and networking in the cancer immunotherapy field. Reserve your spot today!

Register for SITC 2017

cig-big.png

Now Available in JITC

"Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma."

cig-pms-glow.png

Read the Guidelines

Sparkathon_Logo_PNG.png

29 Young Investigators to Lead 2018 SITC Sparkathon Cohort

SITC is excited to announce the 29 early career scientists who will comprise the 2018 Cohort of the SITC Sparkathon, which will enlist young investigators to identify and solve hurdles facing the field of cancer immunotherapy.

Meet the 2018 Cohort

sitc-connect-ed-cmyk_FINAL.png

Begin your free online education today at SITC Cancer Immunotherapy connectED

SITC connectED is the new adaptive learning portal connecting users to online educational activities about cancer immunotherapy with opportunities for continuing education credits. Start with Introduction to Immunology lead by Christian Capitini, MD (University of Wisconsin).

Explore SITC connectED

SITC-blk.png

The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More

sitc_log_white.png

Join the Community– Create a Free SITC Cancer Immunotherapy CONNECT Account

Learn and share information in the SITC Cancer Immunotherapy CONNECT Open Forum! Create a free SITC CONNECT account in a few minutes, upload a profile photo and then join the conversation.

CREATE A SITC CONNECT ACCOUNT

Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Regarding lymphatic endothelial cell-related cancer and post-transplant recipients. Kaposi's sarcoma-associated herpes virus (KSHV or HHV-8) evades immune killing of tumor cells by relying on its immunomodulatory viral antigens. Organ donors in high seroprevalence ...

  • There is likely an unpublished cohort of patients throughout the world who were treated with ipilimumab prior to the introduction of nivolumab/ipilimumab combination and achieved an either complete remission or partial remission.  These patients then ...

    1 person recommends this.
  • The case report presented here on advanced melanoma, in an elderly patient on page 810, indicates that despite of lack of prior ipilimumab treatment it cannot be excluded that subsequent observed astonishing treatment with nivolumab can partially be due ...

    1 person recommends this.

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More